Transition of care interventions to manage severe COVID-19 in the ambulatory setting: a systematic review

Intern Emerg Med. 2024 Apr;19(3):765-775. doi: 10.1007/s11739-023-03493-4. Epub 2023 Dec 17.

Abstract

Background: Severe COVID-19, with the need in supplemental oxygen and hospitalization, leads to major burden on patients and healthcare systems. As a result, safe and effective ambulatory treatment strategies for severe COVID-19 are of urgent need. In this systematic review, we aimed to evaluate interventions to transition care to the ambulatory setting for patients with active severe COVID-19 that required supplemental oxygen.

Methods: We searched Medline, Scopus, Web of Science, and DOAJ databases to identify articles with original data published until the 1st of April 2023. Characteristics and outcomes of interventions to transition care to home management were reviewed. Given the heterogeneous settings and outcomes studied, a meta-analysis was not performed.

Results: Of the 235 studies identified, 11 observational studies, with 2645 patients, were included. The interventions were initiated from the emergency department, observation units or inpatient units, and included continuous home telemonitoring (n = 8), mobile applications (n = 2), and patient-initiated medical contact (n = 3). Included patients had an overall short length of hospital stay, high readmission rates, and positive patients' feedback. There was a lack of prospective controlled data and cost-effectiveness analyses.

Conclusion: Our findings highlight the potential in treating severe COVID-19 at the ambulatory setting and the lack of high-quality data in this field. Dedicated medical teams, adjusted monitoring methods, improving clinical trajectory, and correct inclusion settings are needed for safe and effective transition of care.

Keywords: Home oxygen; Monitoring; Outpatient; SARS-CoV-2; Telehealth.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Ambulatory Care* / methods
  • Ambulatory Care* / organization & administration
  • COVID-19* / therapy
  • Humans
  • SARS-CoV-2
  • Telemedicine / methods
  • Telemedicine / organization & administration